Turbopride-2/Turbopride-4

Turbopride-2/Turbopride-4

glimepiride

Manufacturer:

Healthcare Pharma

Distributor:

San Lwin Trading

Marketer:

San Lwin Trading
Concise Prescribing Info
Contents
Glimepiride
Indications/Uses
NIDDM (type II) whenever blood glucose level cannot be controlled adequately by diet, physical exercise & wt reduction. In combination w/ insulin to lower blood glucose in patients whose hyperglycaemia cannot be controlled by diet & exercise or in conjunction w/ oral hypoglycaemic agent.
Dosage/Direction for Use
Initially 1 mg once daily. May be increased gradually based on glucose levels & carried out stepwise as follows: 1 mg-2 mg-3 mg-4 mg-6 mg. Patient w/ well-controlled diabetes 1-4 mg daily.
Administration
Should be taken with food: Take immediately before breakfast/1st main meal. Swallow whole w/o chewing w/ sufficient amount of liqd (approx ½ glass).
Contraindications
Hypersensitivity to glimepiride, other sulfonylureas & sulfonamides. Not suitable for IDDM (type I) (eg, w/ history of ketoacidosis) or of diabetic precoma or coma.
Special Precautions
Increased risk of hypoglycaemia. Not to be taken during pregnancy & lactation.
Adverse Reactions
Hypoglycaemia, temporary visual impairment, nausea, vomiting, diarrhoea, abdominal pain, urticaria, fall in BP.
Drug Interactions
Potentiation of blood sugar-lowering effect w/ insulin & other oral antidiabetics, ACE inhibitors, allopurinol, anabolic steroids & male sex hormones, chloramphenicol, coumarin derivatives, fluoxetine, MAOIs, miconazole, para-aminosalicylic acid, pentoxifylline (high dose parenteral), phenylbutazone, oxyphenbutazone, quinolones, salicylates, sulfonamides, tetracyclines, β-blockers. Weakening of blood sugar-lowering effect w/ acetazolamide, barbiturates, corticosteroids, diazoxide, diuretics, epinephrine & other sympathomimetic agents, laxatives, oestrogens & progestogens, phenothiazines, phenytoin, rifampicin, thyroid hormones. May potentiate or weaken blood sugar-lowering effect w/ H2-receptor antagonists, clonidine & reserpine; acute & chronic alcohol intake.
MIMS Class
Antidiabetic Agents
ATC Classification
A10BB12 - glimepiride ; Belongs to the class of sulfonylureas. Used in the treatment of diabetes.
Presentation/Packing
Form
Turbopride-2 tab 2 mg
Packing/Price
3 × 10's
Form
Turbopride-4 tab 4 mg
Packing/Price
3 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in